Cargando…

Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies

Patients with inflammatory arthritis (IA) are at increased risk of severe COVID-19 due to medication-induced immunosuppression that impairs host defenses. The aim of this study was to assess antibody and B cell responses to COVID-19 mRNA vaccination in IA patients receiving immunomodulatory therapie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jenny M., Figueroa, Alexis, Sachithanandham, Jaiprasath, Li, Maggie, Connolly, Caoilfhionn M., Shapiro, Janna R., Chen, Yiqun, Jones, Michelle, Dhara, Venkata Gayatri, Towns, Marilyn, Lee, John S., Peralta, Stephanie R., Milstone, Aaron M., Betenbaugh, Michael, Debes, Amanda K., Blankson, Joel, Sitaras, Ioannis, Yoon, Steve, Thompson, Elizabeth A., Bingham, Clifton O., Klein, Sabra L., Pekosz, Andrew, Bailey, Justin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646683/ https://www.ncbi.nlm.nih.gov/pubmed/38022602 http://dx.doi.org/10.3389/fimmu.2023.1266370

Ejemplares similares

Comparison of total and neutralizing SARS-CoV-2 spike antibodies against omicron and other variants in paired samples after two or three doses of mRNA vaccine
por: Debes, Amanda K., et al.
Publicado: (2022)

Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine
por: Debes, Amanda K., et al.
Publicado: (2022)

Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
por: McConnell, Scott A., et al.
Publicado: (2023)

Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults( )
por: Shapiro, Janna R, et al.
Publicado: (2022)

Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron
por: Hardick, Justin, et al.
Publicado: (2022)

Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization
por: Morris, C. Paul, et al.
Publicado: (2022)

Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization
por: Morris, C Paul, et al.
Publicado: (2022)

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
por: Luo, Chun Huai, et al.
Publicado: (2021)

Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
por: Huai Luo, Chun, et al.
Publicado: (2021)

An unconventional uptake rate objective function approach enhances applicability of genome-scale models for mammalian cells
por: Chen, Yiqun, et al.
Publicado: (2019)

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection
por: Park, Han-Sol, et al.
Publicado: (2022)

A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads
por: Fall, Amary, et al.
Publicado: (2022)

The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads
por: Fall, Amary, et al.
Publicado: (2022)

Large Scale SARS-CoV-2 Molecular Testing and Genomic Surveillance Reveal Prolonged Infections, Protracted RNA shedding, and Viral Reinfections
por: Morris, C. Paul, et al.
Publicado: (2022)

Expression of cytokine-mRNA in PBMC of HIV-1 subtype C infected individuals with opportunistic viral infections from South India
por: Sachithanandham, Jaiprasath, et al.
Publicado: (2014)

Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
por: McMahan, Zsuzsanna H, et al.
Publicado: (2014)

Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

Right atrial thrombus and massive pulmonary embolism refractory to thrombolytic therapy: A case report
por: De Freitas, Simon, et al.
Publicado: (2016)

Immune-Related Adverse Events: A Case-Based Approach
por: Connolly, Caoilfhionn, et al.
Publicado: (2019)

Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women
por: St Clair, Laura A., et al.
Publicado: (2023)

Ductus arteriosus aneurysm presenting as hoarseness: successful repair with an endovascular approach
por: De Freitas, Simon, et al.
Publicado: (2016)

Durability of Spike Immunoglobin G Antibodies to SARS-CoV-2 Among Health Care Workers With Prior Infection
por: Egbert, Emily R., et al.
Publicado: (2021)

Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers
por: Debes, Amanda K., et al.
Publicado: (2021)

Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018)

Effect of HIV-1 Subtype C integrase mutations implied using molecular modeling and docking data
por: Sachithanandham, Jaiprasath, et al.
Publicado: (2016)

Identification of novel inhibitory metabolites and impact verification on growth and protein synthesis in mammalian cells
por: Kuang, Bingyu, et al.
Publicado: (2021)

A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates
por: Wang, Qiong, et al.
Publicado: (2021)

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
por: Karaba, Andrew H., et al.
Publicado: (2021)

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2022)

Impact of Converting from Immediate-Release Tacrolimus to Envarsus on BK Viremia Incidence in Kidney Transplant Patients with Rapid Metabolism
por: Towns, Graham, et al.
Publicado: (2023)

Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Frey, Sarah, et al.
Publicado: (2022)

Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
por: Pisanic, Nora, et al.
Publicado: (2022)

Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
por: Pisanic, Nora, et al.
Publicado: (2023)

Immunomodulatory Properties of Defensins and Cathelicidins
por: Bowdish, D. M. E., et al.
Publicado: (2006)

Stop ‘controlling’ for sex and gender in global health research
por: Shapiro, Janna R, et al.
Publicado: (2021)

The impact of sex, gender and pregnancy on 2009 H1N1 disease
por: Klein, Sabra L, et al.
Publicado: (2010)

Animal models of congenital zika syndrome provide mechanistic insight into viral pathogenesis during pregnancy
por: Narasimhan, Harish, et al.
Publicado: (2020)

Durable SARS-CoV-2 B cell immunity after mild or severe disease
por: Ogega, Clinton O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e65ov20ps8dvlsimar2pa6rt96